Sorrento Therapeutics
SRNEQ
#10205
Rank
S$21.18 M
Marketcap
S$0.03842
Share price
3.45%
Change (1 day)
-91.95%
Change (1 year)

Sorrento Therapeutics (SRNEQ) - Total liabilities

Total liabilities on the balance sheet as of June 2023 : S$0.83 Billion

According to Sorrento Therapeutics 's latest financial reports the company's total liabilities are S$0.83 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Sorrento Therapeutics - Total liabilities on balance sheet (from 2004 to 2023)

Total liabilities by year

Year Total liabilities Change
2022-12-31S$0.66 B-20.48%
2021-12-31S$0.83 B59.51%
2020-12-31S$0.52 B-26.14%
2019-12-31S$0.70 B24.34%
2018-12-31S$0.56 B89.11%
2017-12-31S$0.30 B-34.01%
2016-12-31S$0.45 B59.14%
2015-12-31S$0.28 B560.62%
2014-12-31S$43.37 M32.84%
2013-12-31S$32.65 M4470.91%
2012-12-31S$0.71 M53.51%
2011-12-31S$0.46 M-40.18%
2010-12-31S$0.77 M56.95%
2009-12-31S$0.49 M195.11%
2008-12-31S$0.16 M3453.17%
2007-12-31S$0 M-99.35%
2006-12-31S$0.72 M1236.91%
2005-12-31S$0.05 M-90.26%
2004-12-31S$0.55 M-3.76%
2003-12-31S$0.57 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Karyopharm Therapeutics
KPTI
S$0.46 B-44.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
S$0.84 B 1.25%๐Ÿ‡บ๐Ÿ‡ธ USA